Eric Cheng

Mr. Cheng has more than two decades of experience as an investment banker focused on the healthcare sector, during which time he has completed over 200 transactions representing over $13 billion in aggregate value. In addition to his investment banking expertise, prior to returning to Maxim in 2022, Mr. Cheng obtained buyside experience as managing director at Altium Capital Management, LP where he focused on private and public investments within the healthcare sector and served as Chief Business Officer for Altium’s SPAC, Medicus Sciences Acquisition Corp. Prior to these buyside roles, Mr. Cheng was Co-Head of Healthcare Investment Banking at Roth Capital Partners. Prior to Roth, from 2011 to 2017, Mr. Cheng was Senior Managing Director and Head of Healthcare Investment Banking at Maxim. He has also served as an investment banker at BMO Capital Markets, WR Hambrecht & Co., Deutsche Bank Securities and Lehman Brothers. Mr. Cheng began his career as a public accountant at Deloitte & Touche in 1992 and earned his B.A. from the University of California at Los Angeles and his M.B.A. from Columbia Business School.